ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 30 医学部・医学研究科・保健学研究科
  2. 30b 弘前医学 = Hirosaki Medical Journal
  3. 73巻1-4号

Combined utility of maximum standardized uptake value and its change after neoadjuvant chemotherapy in predicting postoperative recurrence in esophageal cancer

http://hdl.handle.net/10129/00008201
http://hdl.handle.net/10129/00008201
51f7ba51-d223-4bb3-a901-720ec9e9d344
名前 / ファイル ライセンス アクション
Hirosaki Hirosaki Med J 73-1-4_54 (1.6 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2023-04-24
タイトル
タイトル Combined utility of maximum standardized uptake value and its change after neoadjuvant chemotherapy in predicting postoperative recurrence in esophageal cancer
言語
言語 eng
キーワード
主題Scheme Other
主題 esophageal cancer
キーワード
主題Scheme Other
主題 fluorodeoxyglucose positron emission tomography
キーワード
主題Scheme Other
主題 standardised uptake value
キーワード
主題Scheme Other
主題 prognostic factor
キーワード
主題Scheme Other
主題 neoadjuvant therapy
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Saito, Kensuke

× Saito, Kensuke

Saito, Kensuke

Search repository
Yoshizawa, Tadashi

× Yoshizawa, Tadashi

Yoshizawa, Tadashi

Search repository
Morohashi, Satoko

× Morohashi, Satoko

Morohashi, Satoko

Search repository
Seino, Hiroko

× Seino, Hiroko

Seino, Hiroko

Search repository
Goto, Shintaro

× Goto, Shintaro

Goto, Shintaro

Search repository
Muroya, Takahiro

× Muroya, Takahiro

Muroya, Takahiro

Search repository
Yokoyama, Hiroshi

× Yokoyama, Hiroshi

Yokoyama, Hiroshi

Search repository
Yoshida, Eri

× Yoshida, Eri

Yoshida, Eri

Search repository
Miura, Hiroyuki

× Miura, Hiroyuki

Miura, Hiroyuki

Search repository
Yu, Chen

× Yu, Chen

Yu, Chen

Search repository
Kijima, Hiroshi

× Kijima, Hiroshi

Kijima, Hiroshi

Search repository
Kakeda, Shingo

× Kakeda, Shingo

Kakeda, Shingo

Search repository
Hakamada, Kenichi

× Hakamada, Kenichi

Hakamada, Kenichi

Search repository
Sato, Atsushi

× Sato, Atsushi

Sato, Atsushi

Search repository
著者所属
値 Department of Medical Oncology, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Radiology, Aomori National Hospital
著者所属
値 Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Radiology, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Medical Oncology, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Radiology, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine
著者所属
値 Department of Medical Oncology, Hirosaki University Graduate School of Medicine
抄録
内容記述タイプ Abstract
内容記述 Background: Positron emission tomography(PET) is the standard method for metabolic and quantitative evaluation of therapeutic response to chemotherapy in solid tumors. This study determined the ability of PET parameters used in combination in predicting recurrence-free survival(RFS)after neoadjuvant chemotherapy (NAC)and operation for esophageal cancer.
Methods: This single-center retrospective study included 96 patients who underwent 18F-fluorodeoxyglucose-PET/computed tomography before and after NAC. Maximum standardised uptake value(SUVmax)after NAC and the rate of change in SUVmax following NAC(ΔSUVmax)were determined to examine their relationship with postoperative recurrence and clinicopathological factors.
Results: Receiver operating characteristic curves, with recurrence after NAC as the event, were used to determine optimal cut-off SUVmax and ΔSUVmax of 6.8 and 45.7, respectively. Using these cut-off values, the patients were classified into four groups: Group A, SUVmax > 6.8 and ΔSUVmax ≤ 45.7; Group B, SUVmax > 6.8 and ΔSUVmax > 45.7; Group C, SUVmax ≤ 6.8 and ΔSUVmax ≤ 45.7; and Group D, SUVmax ≤ 6.8 and ΔSUVmax > 45.7. Of the four groups, Group D had the longest RFS compared to the other groups.
Conclusion: Combination of SUVmax with ΔSUVmax was useful for evaluating the effects of NAC in patients with esophageal cancer.
書誌情報 弘前医学
en : Hirosaki Medical Journal

巻 73, 号 1-4, p. 54-66, 発行日 2023-03-22
ISSN
収録物識別子タイプ ISSN
収録物識別子 0439-1721
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00211444
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
出版者
出版者 弘前大学大学院医学研究科
資源タイプ
値 Article
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 09:27:22.647602
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3